Form 8-K - Current report:
SEC Accession No. 0001193125-24-237838
Filing Date
2024-10-16
Accepted
2024-10-16 06:06:59
Documents
18
Period of Report
2024-10-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d816394d8k.htm   iXBRL 8-K 34950
2 EX-4.1 d816394dex41.htm EX-4.1 78993
3 EX-4.2 d816394dex42.htm EX-4.2 74949
4 EX-5.1 d816394dex51.htm EX-5.1 14720
5 EX-10.1 d816394dex101.htm EX-10.1 166682
9 GRAPHIC g816394g1016064936651.jpg GRAPHIC 2537
  Complete submission text file 0001193125-24-237838.txt   598733

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA rani-20241015.xsd EX-101.SCH 2879
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE rani-20241015_lab.xml EX-101.LAB 17980
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rani-20241015_pre.xml EX-101.PRE 11278
20 EXTRACTED XBRL INSTANCE DOCUMENT d816394d8k_htm.xml XML 3650
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40672 | Film No.: 241373217
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)